Novartis | Leverandørgjeld

Trade Creditors Endring Dato
Alcon AG USD 818M 7M 2024-03
Almirall EUR 270.61M 77.04M 2023-12
Amgen USD 1.63B 270M 2024-03
Bayer EUR 6.4B 1.06B 2024-03
Biogen USD 387M 16.3M 2024-03
Bristol-Myers Squibb USD 3.54B 726M 2024-03
Eli Lilly USD 2.47B 38.6M 2024-03
Fresenius EUR 1.25B 237M 2024-03
Fresenius Medical Care EUR 835.41M 82.29M 2024-03
Galapagos EUR 145.55M 10.4M 2024-03
Gilead Sciences USD 622M 36M 2024-03
GRIFOLS EUR 813.11M 104.14M 2023-12
Hikma Pharmaceutical USD 309M 18M 2023-12
J&J USD 8.17B 181M 2024-03
Lonza CHF 468M 9M 2023-12
Merck EUR 2.09B 459M 2024-03
Merck USD 3.51B 5M 2024-03
Novartis USD 4.06B 864M 2024-03
Novartis USD 4.06B 864M 2024-03
Orion EUR 83.8M 18.5M 2024-03
Pfizer USD 5.59B 253M 2024-03
Philips EUR 1.92B 271M 2023-12
Recordati EUR 288.38M 35.56M 2024-03
Regeneron Pharmaceuticals USD 671.3M 134.7M 2024-03



Novartis Leverandørgjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.